About The Report
The global endoscope reprocessing device sector is on track to achieve a valuation of USD 5.30 billion by 2036, accelerating from USD 2.88 billion in 2026 at a CAGR of 6.3%. As per Future Market Insights, expansion is structurally underpinned by the growing volume of endoscopic procedures globally and the persistent regulatory pressure to prevent healthcare-associated infections from contaminated flexible endoscopes. The USA Food and Drug Administration issued supplemental guidance in 2024 on the reprocessing of duodenoscopes with elevator channels, reinforcing the need for validated high-level disinfection and sterilization protocols.
This regulatory pressure compels hospitals and ambulatory surgery centers to invest in automated endoscope reprocessors (AERs) that provide documented, traceable reprocessing cycles. Simultaneously, the industry is shifting from manual reprocessing to fully automated systems with digital compliance tracking.
The Olympus Press Office stated: 'India, endoscopic procedures already outnumber those in Japan and are expected to grow further, and infection control systems are still evolving.' In October 2024, Olympus received CE-mark approval under the Medical Device Regulation (MDR) for three cloud-based AI medical devices (CADDIE, CADU, and SMARTIBD), forming the foundation of its Intelligent Endoscopy Ecosystem. FMI opines that Olympus's AI ecosystem strategy, which connects hardware, AI software, and data services, will reshape the reprocessing market by creating an integrated value chain where endoscope cleaning verification is digitally linked to clinical outcome data.
The operational reality for endoscope reprocessing suppliers is defined by the need to balance infection control stringency with procedure turnaround time in high-volume endoscopy suites. As per FMI, the endoscope reprocessing market is structurally driven by the growing gap between rising procedure volumes (particularly colonoscopy screening driven by colorectal cancer guidelines) and the limited number of reusable endoscopes available per facility. FMI is of the opinion that single-use endoscope adoption, while growing, will not replace reusable platforms within the forecast period due to cost and sustainability concerns, which sustains the demand for high-throughput AER systems with rapid cycle times.
Future Market Insights projects the endoscope reprocessing device market to expand at a CAGR of 6.3% from 2026 to 2036, increasing from USD 2.88 Billion in 2026 to USD 5.30 Billion by 2036.
FMI Research Approach: FMI proprietary forecasting model based on endoscopic procedure volumes and AER installed base replacement cycles.
FMI analysts perceive the market evolving toward digitally verified sterility assurance where automated reprocessors integrate with cloud-based AI endoscopy ecosystems to provide traceable compliance documentation.
FMI Research Approach: Olympus AI endoscopy ecosystem CE-mark (October 2024) and FDA duodenoscope reprocessing guidance (2024).
The United States holds a significant share, supported by the highest endoscopic procedure volume per capita, stringent FDA reprocessing guidelines, and the largest AER installed base.
FMI Research Approach: FMI country-level revenue modeling by endoscopy procedure volumes and AER procurement data.
The global endoscope reprocessing device market is projected to reach USD 5.30 Billion by 2036.
FMI Research Approach: FMI long-term revenue forecast derived from colorectal cancer screening guideline expansion and AER replacement cycles.
The endoscope reprocessing device market includes revenue from automated endoscope reprocessors, manual cleaning accessories, sterility verification systems, and digital compliance tracking platforms used to decontaminate flexible and semi-rigid endoscopes.
FMI Research Approach: FMI market taxonomy aligned with FDA and MDR endoscope reprocessing classifications.
Globally unique trends include the integration of AI-connected endoscopy ecosystems with reprocessing workflows, tightening FDA duodenoscope reprocessing requirements, and the rapid growth of endoscopic procedure volumes in India surpassing Japan.
FMI Research Approach: Olympus AI ecosystem CE-mark (October 2024) and FDA duodenoscope guidance (2024).
| Metric | Details |
|---|---|
| Industry Size (2026) | USD 2.88 Billion |
| Industry Value (2036) | USD 5.30 Billion |
| CAGR (2026 to 2036) | 6.3% |
Source: Future Market Insights (FMI) analysis, based on proprietary forecasting model and primary research
Regulatory bodies around the world have introduced stringent measures for the reprocessing of medical devices. Endoscopes come within that purview, necessitating the increased use of reprocessing devices in healthcare facilities.
Non-compliance with these regulations has the ability to incur severe punishments, including penalties, loss of accreditation, and reputational damage, not to mention harm to patients. Hence, healthcare facilities are diligently adopting reprocessing devices.
The following table provides the various regulatory bodies that mandate the use of reprocessing devices.
| Regulatory Body | Recommendations |
|---|---|
| Centers for Disease Control and Prevention (CDC) | Use of high-level disinfection and sterilization for semi-critical devices like endoscopes |
| Association for the Advancement of Medical Instrumentation (AAMI) | Standards like AAMI ST91 for reprocessing endoscopes |
| Food and Drug Administration (FDA) | Manufacturers are required to provide data that reprocessing has been effective for endoscopes |
| European Union Medical Device Regulation (EU MDR) | Stringent rules regarding the use of endoscopes in Europe |
The following table highlights some of the recent innovations and their impact.
| Innovation | Impact |
|---|---|
| Modern automatic endoscope reprocessors (AERs) | Handling of multiple scopes simultaneously. |
| Hydrogen Peroxide Vapor or Ozone-Based Systems | Faster, safer, and eco-friendlier working. |
| Barcode Scanning and Digital Record-Keeping | Tracking of every step in the reprocessing cycle. |
| Eco-Friendly Disinfectants | Adding to more sustainability oriented healthcare settings. |
Advanced automatic endoscope reprocessors and sterilization systems are costly and require a high initial investment. Most healthcare facilities, especially in developing regions, cannot afford to spend such large amounts of money.
Regular maintenance of the reprocessing device is necessary for its efficacy and compliance with the standards. This increases cost in the form of service charges and maintenance contracts. Consumables used in the reprocessing activity, like high-level disinfectants, enzymatic detergents, sterile water, and filters, can also be cost-intensive.
Quite often, sophisticated devices for reprocessing require upgrading infrastructures such as dedicated spaces, water supply, and ventilation. Installation and operation are prohibitive for small hospitals and clinics.
Adequate training of the staff operating these devices and following the reprocessing protocols is needed. Training programs are expensive and take a long time to initiate, especially in institutions with rapid turnover rates among the personnel. Hence, the labor costs associated with the devices is also high.
Large Number of Endoscopies Performed in Hospitals Leading to Greater Use of Endoscopy Reprocessing Devices
| Attributes | Details |
|---|---|
| Top End Use | Hospitals |
| Market Share in 2026 | 55.6% |
Hospitals are the primary end users of endoscopy reprocessing devices. This segment is likely to account for 55.6% of the value share in 2026.
Most endoscopy procedures are performed in hospitals. Patients and their relatives have an implicit trust in hospitals and their staff. As a result, the number of endoscopies is increasing substantially in hospitals. This is leading to more recourse towards endoscopy reprocessing devices.
Safety and Efficiency of Automated Endoscope Reprocessors Preferred by End Users
| Attributes | Details |
|---|---|
| Top Product | Automated Endoscope Reprocessor |
| Market Share in 2026 | 45.3% |
Endoscopy reprocessing devices are majorly used in the form of automated endoscope reprocessors. These reprocessors is likely to account for 45.3% of the value share in 2026.
The automated endoscope reprocessor segment is the most significant in the market for endoscopy reprocessing devices, mainly attributed to its efficiency and safety. Automated cleaning and disinfection by AERs significantly reduce processing time, enabling high throughput, which is necessary for busy healthcare settings. It minimizes human contact with contaminated instruments, thus lowering the risk of cross-contamination and ensuring consistent adherence to protocols.
Besides, AERs meet high regulatory requirements by offering automated tracking and documentation which further increases compliance and quality assurance. Moreover, advances in technology have allowed them to integrate with hospital systems and make user-friendly features that enhance their reliability and usability.
With the increased focus on infection control and patient safety, AERs are being adopted by more and more healthcare facilities. Though the initial investment is higher, the long-term savings in labor costs and reduced equipment damage make AERs a cost-effective choice.
Increased Efficiency Provided by Automatic Devices Help End Users
Automatic endoscopy processing devices are preferred over semi-automatic devices because they are efficient, safe, and reliable. They fully automate the cleaning and disinfection processes, reducing the time required for reprocessing, which also minimizes the risk of human error.
Moreover, automatic devices provide integrated tracking and documentation features, which help meet regulatory standards. Overall, their ability to streamline workflows and improve safety makes automatic endoscopy processing devices the favored choice in healthcare settings.
Mobile Reprocessing Devices Provide Enhanced Flexibility
Mobile processing devices are more favored than flat-top ones due to the advantage of portability, which facilitates easy shifting from one place to another in healthcare facilities. These provide easy reprocessing throughout the facility with minimal need for dedicated spaces, especially in busy environments, thus optimizing workflow and maximizing space utilization.
Mobile devices also can be readily mobilized to meet variable demands and improve operational efficiency. Overall, the portability and usability of mobile endoscopy processing devices make them a more viable option for healthcare settings.
| Countries | CAGR 2026 to 2036 |
|---|---|
| United States | 4% |
| Japan | 2.6% |
| India | 10.4% |
| Germany | 4% |
| South Korea | 9.5% |
The Japan endoscope reprocessing device market is estimated to advance at a CAGR of 2.6% over the 2026 to 2036 period. In Japan, a high number of patients are preferring minimally invasive surgeries. These surgeries require precise operation of tools and reprocessing devices enable this smooth operation.
Japanese manufacturers are prominent not only locally but worldwide. Japanese companies like Olympus are leaders, providing novel products to the worldwide market. While there is concern over the limited budget available to hospitals in rural areas of Japan, there are still a plethora of opportunities in the country for companies.
The endoscope reprocessing device market in Germany is expected to register a CAGR of 4% from 2026 to 2036. Germany has one of the leading healthcare sectors in Europe. As a result, smart reprocessing systems with AI and machine learning capabilities are becoming popular in the country.
In Germany, rules mandated by various regulatory authorities make reprocessing devices necessary in healthcare settings. The European Union Medical Device Regulation (EU MDR) and Robert Koch Institute (RKI) guidelines are two such standards mandating strict infection protection protocols, necessitating the use of reprocessing devices.
The endoscope reprocessing device market in South Korea is expected to register a CAGR of 9.5% from 2026 to 2036. The South Korean healthcare sector is benefitting from increased government investment in medical facilities. Schemes like the Korea Health Industry Development Institute (KHIDI) increase the adoption of apparatus like endoscopy reprocessing devices.
Another notable factor in South Korea is the rising medical tourism in the country. The proliferation of 5G in the country is enabling healthcare facilities to have advanced equipment, including IoT-enabled endoscopy reprocessing devices. As a result, tourists from all over the world are traveling to South Korea for procedures like endoscopies.
The endoscope reprocessing device market in the United States is set to progress at a CAGR of 4% from 2026 to 2036. The healthcare system in the United States is robust and provides impetus for novel products. As a result, reprocessing devices that enable integration with Electronic Health Records (EHR) as well as IoT-enabled devices are becoming more popular in the country.
Regulatory authorities like the Centers for Disease Control and Prevention (CDC), FDA, and the Association for the Advancement of Medical Instrumentation (AAMI) make it mandatory for endoscopy devices to be kept in proper order. Hence, endoscope reprocessing device sales are shooting up.
Another key factor shaping the landscape in the country is the rising number of the geriatric population. This segment of the population requires endoscopy frequently, leading to more use of reprocessing devices.
The striving for technological progress in the healthcare sector is also reflected in the endoscopy reprocessing device market. With the help of technology, players aim to keep the product line moving and endoscope reprocessing device sales consistent.
One of the notable product launches was Getinge AB launching Enhanced ED-Flow AER in June 2022. It was an updated version of the ED-Flow Automated Endoscope Reprocessor (AER), making significant strides in digital connectivity and data management.
Recognizing the rising importance of endoscopy reprocessing devices, several healthcare companies are entering or expanding their presence in the market. For instance, HOYA Corporation acquired Wassenburg Medical B.V. in November 2023. Wassenburg is a prominent manufacturer of these devices and thus HOYA expanded its footprint in the market through the acquisition.
Recent Developments:
The endoscope reprocessing device market represents revenue from equipment and systems used to clean, disinfect, and sterilize flexible and semi-rigid endoscopes between patient uses in hospitals, ambulatory surgery centers, and endoscopy clinics.
Inclusions cover automated endoscope reprocessors (AERs), manual cleaning brushes and detergents, high-level disinfectants, sterility verification test strips, and digital reprocessing compliance tracking software.
Exclusions include endoscope manufacturing and sales, single-use disposable endoscopes, and general hospital sterilization equipment not specific to endoscope reprocessing. Operating room instrument sterilizers are outside scope.
| Items | Values |
|---|---|
| Quantitative Units (2026) | USD 2.88 Billion |
| Product Type | Automated Endoscope Reprocessors, Manual Cleaning Accessories, Disinfectants, Digital Compliance Systems |
| End User | Hospitals, Ambulatory Surgery Centers, Endoscopy Clinics |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Key Companies Profiled | Olympus, Cantel Medical (Medivators), Getinge, Steelco (SteelcoBelimed), Wassenburg Medical |
The market is segmented into automated endoscope reprocessors, washer disinfectors, sterilizers, ultrasonic washers, and drying & storage cabinets based on the product.
Based on the operation mode, the market is bifurcated into semiautomatic and automatic.
In terms of modality, the market is segmented into floor standing/bench top and mobile.
In terms of end users, the market is segmented into hospitals, specialty clinics, ambulatory surgical centers, academic & research institutes, and the Central Sterile Services Department (CSSD).
Based on the region, the market is segmented into North America, Latin America, Europe, South Asia, East Asia, Middle East & Africa, and Oceania.
The global market is valued at USD 2.88 Billion in 2026, driven by rising endoscopic procedure volumes globally and heightened regulatory scrutiny on flexible endoscope contamination and infection control.
The market is projected to grow at a CAGR of 6.3% from 2026 to 2036.
Asia Pacific leads with India's endoscopic procedure volumes surpassing Japan, followed by North America driven by FDA reprocessing compliance requirements and colorectal cancer screening expansion.
FDA duodenoscope reprocessing guidelines and the integration of AI-connected endoscopy ecosystems requiring digitally verified sterility assurance are the primary growth catalysts.
Olympus, Cantel Medical (Medivators), Getinge, SteelcoBelimed, and Wassenburg Medical are key players, differentiating through AI-connected reprocessing ecosystems and automated high-throughput AER platforms.
Our Research Products
The "Full Research Suite" delivers actionable market intel, deep dives on markets or technologies, so clients act faster, cut risk, and unlock growth.
The Leaderboard benchmarks and ranks top vendors, classifying them as Established Leaders, Leading Challengers, or Disruptors & Challengers.
Locates where complements amplify value and substitutes erode it, forecasting net impact by horizon
We deliver granular, decision-grade intel: market sizing, 5-year forecasts, pricing, adoption, usage, revenue, and operational KPIs—plus competitor tracking, regulation, and value chains—across 60 countries broadly.
Spot the shifts before they hit your P&L. We track inflection points, adoption curves, pricing moves, and ecosystem plays to show where demand is heading, why it is changing, and what to do next across high-growth markets and disruptive tech
Real-time reads of user behavior. We track shifting priorities, perceptions of today’s and next-gen services, and provider experience, then pace how fast tech moves from trial to adoption, blending buyer, consumer, and channel inputs with social signals (#WhySwitch, #UX).
Partner with our analyst team to build a custom report designed around your business priorities. From analysing market trends to assessing competitors or crafting bespoke datasets, we tailor insights to your needs.
Supplier Intelligence
Discovery & Profiling
Capacity & Footprint
Performance & Risk
Compliance & Governance
Commercial Readiness
Who Supplies Whom
Scorecards & Shortlists
Playbooks & Docs
Category Intelligence
Definition & Scope
Demand & Use Cases
Cost Drivers
Market Structure
Supply Chain Map
Trade & Policy
Operating Norms
Deliverables
Buyer Intelligence
Account Basics
Spend & Scope
Procurement Model
Vendor Requirements
Terms & Policies
Entry Strategy
Pain Points & Triggers
Outputs
Pricing Analysis
Benchmarks
Trends
Should-Cost
Indexation
Landed Cost
Commercial Terms
Deliverables
Brand Analysis
Positioning & Value Prop
Share & Presence
Customer Evidence
Go-to-Market
Digital & Reputation
Compliance & Trust
KPIs & Gaps
Outputs
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Demand for Endoscope Reprocessing Device in Japan Size and Share Forecast Outlook 2025 to 2035
Demand for Endoscope Reprocessing Device in USA Size and Share Forecast Outlook 2025 to 2035
Endoscope Reprocessing Chemicals Market Size and Share Forecast Outlook 2026 to 2036
Endoscope Reprocessing Market Analysis - Size, Share, and Forecast Outlook 2025 to 2035
Endoscope Leak Detection Device Market
Endoscope Protective Barrier Covers Market Size and Share Forecast Outlook 2025 to 2035
Endoscope Procedure Kits Market Size and Share Forecast Outlook 2025 to 2035
Device-Embedded Biometric Authentication Market Size and Share Forecast Outlook 2025 to 2035
Endoscope Detergents And Disinfectants Market Size and Share Forecast Outlook 2025 to 2035
Endoscope Tracking Solutions Market
IoT Device Management Market Size and Share Forecast Outlook 2025 to 2035
IoT Device Management Platform Market Size and Share Forecast Outlook 2025 to 2035
Sialendoscopes Market Size and Share Forecast Outlook 2025 to 2035
Drug Device Combination Products Market Size and Share Forecast Outlook 2025 to 2035
FBAR Devices Market
X-Ray Device Market Size and Share Forecast Outlook 2025 to 2035
Power Device Analyzer Market Growth – Trends & Forecast 2025 to 2035
Snare devices Market
Timing Devices Market Size and Share Forecast Outlook 2026 to 2036
C-Arms Devices Market Size and Share Forecast Outlook 2025 to 2035
Endoscope Reprocessing Device Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
